Ionis Pharmaceuticals Inc financial data

Symbol
IONS on Nasdaq
Location
2855 Gazelle Court, Carlsbad, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
ISIS PHARMACEUTICALS INC (to 12/18/2015)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 729 % -7.5%
Quick Ratio 8.36 % +10.6%
Debt-to-equity 616 % +16.7%
Return On Equity -90.8 % -8475%
Return On Assets -12.5 % +13.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 158M shares +10.1%
Common Stock, Shares, Outstanding 158M shares +10.1%
Entity Public Float 4.24B USD +11.5%
Common Stock, Value, Issued 158K USD +10.5%
Weighted Average Number of Shares Outstanding, Basic 149M shares +3.68%
Weighted Average Number of Shares Outstanding, Diluted 149M shares +3.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 325M USD +114%
Revenue from Contract with Customer, Excluding Assessed Tax 803M USD +30.6%
Costs and Expenses 1.17B USD +0.24%
Operating Income (Loss) -370M USD +33.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -356M USD +5.26%
Income Tax Expense (Benefit) 3.02M USD -91.1%
Net Income (Loss) Attributable to Parent -359M USD +12.4%
Earnings Per Share, Basic -2.44 USD/shares +15%
Earnings Per Share, Diluted -2.44 USD/shares +15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 335M USD -4.96%
Inventory, Net 28.5M USD +11%
Other Assets, Current 184M USD +1.72%
Assets, Current 2.71B USD +5%
Property, Plant and Equipment, Net 82.5M USD +16.3%
Operating Lease, Right-of-Use Asset 164M USD -5.67%
Other Assets, Noncurrent 120M USD +15.6%
Assets 3.08B USD +5.02%
Accounts Payable, Current 9.05M USD +61.2%
Employee-related Liabilities, Current 40.6M USD +20.1%
Accrued Liabilities, Current 124M USD +4.56%
Contract with Customer, Liability, Current 76M USD -62.9%
Liabilities, Current 305M USD -24.7%
Contract with Customer, Liability, Noncurrent 174M USD -30.3%
Operating Lease, Liability, Noncurrent 168M USD -2.7%
Other Liabilities, Noncurrent 41.7M USD -14.5%
Liabilities 2.42B USD -7.63%
Accumulated Other Comprehensive Income (Loss), Net of Tax -24.2M USD +47.5%
Retained Earnings (Accumulated Deficit) -2.15B USD -20.1%
Stockholders' Equity Attributable to Parent 662M USD +110%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 315M USD -46.9%
Liabilities and Equity 3.08B USD +5.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -150M USD -11.9%
Net Cash Provided by (Used in) Financing Activities 23.6M USD -95.2%
Net Cash Provided by (Used in) Investing Activities 76.1M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 158M shares +10.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.4M USD -255%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 335M USD -4.96%
Interest Paid, Excluding Capitalized Interest, Operating Activities 95K USD +6.74%
Deferred Tax Assets, Valuation Allowance 978M USD +20.9%
Deferred Tax Assets, Gross 1.03B USD +19.5%
Operating Lease, Liability 179M USD -3.86%
Depreciation 2.55M USD -2.19%
Payments to Acquire Property, Plant, and Equipment 4.49M USD -57.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -337M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid 280M USD -6.7%
Operating Lease, Liability, Current 8.09M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.6M USD +1.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.4M USD +1.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +0.68%
Deferred Tax Assets, Operating Loss Carryforwards 78M USD -11.2%
Unrecognized Tax Benefits 43.3M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.8M USD +0.09%
Amortization of Intangible Assets 639K USD +5.27%
Share-based Payment Arrangement, Expense 120M USD +14.5%
Interest Expense 17.4M USD +76.5%